联合王国的卫生保健在2025年随着人工智能和突破性治疗而发展,尽管由于关注,医生的收养有限。 UK healthcare advanced in 2025 with AI and breakthrough therapies, despite limited doctor adoption due to concerns.

2025年,英国医疗保健将通过将人工智能整合到NHS诊断,罕见疾病研究和免疫治疗中,取得进步. In 2025, UK healthcare advanced through AI integration in NHS diagnostics, rare disease research, and immunotherapy. 人工智能工具改善了癌症检测、骨折识别和心脏分析,尽管由于安全和隐私问题,只有21%的医生使用这些工具。 AI tools improved cancer detection, fracture identification, and cardiac analysis, though only 21% of doctors used them due to safety and privacy concerns. MAHRA启动了一个全国AI监管委员会,以加速收养。 The MHRA launched a national AI regulatory commission to accelerate adoption. 突破包括基因治疗延缓亨廷顿病情发展75%, Tplizumab将1型糖尿病延后三年, 英国开发的CAR-T疗法在77%重症白血病复发病患者中获得康复。 Breakthroughs included a gene therapy slowing Huntington’s disease progression by 75%, teplizumab delaying type 1 diabetes by three years, and a UK-developed CAR-T therapy achieving remission in 77% of relapsed leukemia patients. 建议对晚期子宫颈癌使用两种新的免疫疗法组合。 Two new immunotherapy combinations were recommended for advanced endometrial cancer. 由人口老化、人手短缺和成本上升所驱动的AI的长期影响是真实的, 且可持续、一体化的AI系统有望改变护理提供。 Despite hype, healthcare leaders agree AI’s long-term impact is real, driven by aging populations, staffing shortages, and rising costs, with sustainable, integrated AI systems expected to transform care delivery.